RecruitingPhase 2Phase 3ACTRN12605000133639

The effect of heparin on lung function following cardiopulmonary bypass.

The effect of heparin on alveolar dead space following cardiopulmonary bypass.


Sponsor

Nil

Enrollment

30 participants

Start Date

Nov 30, 2004

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria1

  • Adult patients undergong elective cardiac surgery for coronary artery bypass grafting with cardiopulmonary bypass.

Exclusion Criteria1

  • Previous adverse reaction to heparin. Active bleeding. An additional surgical procedure to coronary artery bypass grafting planned. Creatinine >200umol/L.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A double blind randomised trial comparing intravenous heparin versus placebo (5% glucose). The infusion will be commenced 8 - 10 hours prior to commencement of surgery and ceased prior to the inserti

A double blind randomised trial comparing intravenous heparin versus placebo (5% glucose). The infusion will be commenced 8 - 10 hours prior to commencement of surgery and ceased prior to the insertion of lines or sternotomy.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000133639